Verve Therapeutics, Inc. Common Stock

Go to Verve Therapeutics, Inc. Common Stock Website

$6.41

(%)
Live
Previous Close

$6.41

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$537.9 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target P...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Related tickers: PODD, VERV.

Read Full Article

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. Verve Therapeutics Inc (NASDAQ:

Related tickers: GILD, UNH, VERV.

Read Full Article
Trending Tickers
LASE

XNAS

$2.04
(%)
PACW

XNAS

$7.54
(%)
SMFL

XNAS

$3.58
(%)
SQ

XNYS

$69.47
(%)
MLGO

XNAS

$0.00
(%)